The global On Body Drug Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry.
- The market is driven by several factors, including the increasing demand for advanced healthcare services globally.
- Advancements in medical technology.
- Growing geriatric population.
- Rising healthcare expenditure.
- Increasing awareness about early disease diagnosis and treatment.
ReportPrime, Inc. (LPI) ' newest research report, the “On Body Drug Delivery System Industry Forecast” looks at past sales and reviews total world On Body Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected On Body Drug Delivery System sales for 2025 through 2031.
This Insight Report provides a comprehensive analysis of the global On Body Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.
This report also analyzes the strategies of leading global companies with a focus on On Body Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global On Body Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for On Body Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.
- Segmentation by Type:
- Wearable Injectors
- Auto-Injectors
- Patches
- Others
- Segmentation by Application:
- Hospital
- Clinic
- Ambulatory Surgery Center
- Market by Region:
- Americas
- APAC
- Europe
- Middle East & Africa
Company coverage:
- BD
- NOVO Engineering
- Elcam Medical
- Enable Injections
- Phillips-Medisize
- Stevanato Group
- Ypsomed AG
- Insulet Corporation
- Tandem Diabetes Care
- Medtronic
Key Questions Addressed in this Report
- What is the 10-year outlook for the global On Body Drug Delivery System market?
- What factors are driving On Body Drug Delivery System market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do On Body Drug Delivery System market opportunities vary by end market size?
- How does On Body Drug Delivery System break out by Type, by Application?
Frequently Asked Questions
What is the USP of the report? expand_more
What are the key content of the report? expand_more
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market